← Leaderboards
Laszlo Virag
Inotek Pharmaceuticals Corporation
$589,279
Attributed
$589,279
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$589,279 · 3
By mechanism
R43$589,279 · 3
Top collaborators
No co-investigators on record.
Most similar at Inotek Pharmaceuticals Corporation
Same institution · by research overlap
- Csaba Szabo$15,264,870
- Andrew L Salzman$19,918,828
- Garry John Southan$13,828,224
- Prakash Jagtap$6,029,479
- Kanneganti Murthy$5,565,701
Others in their field
Top investigators on “Drug Screening /Evaluation”
- Fred M Gordin · Social And Scientific Systems, Inc.$68,001,399
- John C S Breitner · Johns Hopkins University$33,065,187
- Philip J Disaia · University Of California Irvine$21,551,991
- George R Painter · Chimerix, Inc.$19,230,662
- Gregory H Reaman · National Childhood Cancer Foundation$17,052,970
- Stephen J Durako · Westat, Inc.$15,048,684
Research focus
Drug Screening /EvaluationDrug Design /Synthesis /ProductionPentosyltransferasePeroxynitritesEnzyme InhibitorsLaboratory MouseCell LineCytoprotectionDna RepairDosageDrug Adverse EffectFree RadicalsHistologyImmunochemistryLaboratory RabbitLaboratory RatMyocardial Ischemia /HypoxiaNeoplasm /Cancer Radiation TherapyNitric OxidePharmacokineticsRadiosensitizerReperfusionAntiarthritic AgentWater Solubility